Moderna Says FDA Agrees to Consider Revised mRNA Influenza Vaccine Application
Favicon 
yubnub.news

Moderna Says FDA Agrees to Consider Revised mRNA Influenza Vaccine Application

The Moderna campus in Norwood, Mass., on Dec. 2, 2020. Joseph Prezioso/AFP via Getty ImagesModerna on Feb. 18 said the Food and Drug Administration has agreed to review a revised application from the…